Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 424

    1.

    Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection.

    Sung L, Nathan PC, Alibhai SM, Tomlinson GA, Beyene J.

    Ann Intern Med. 2007 Sep 18;147(6):400-11.PMID: 17876022 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy.

    Herbst C, Naumann F, Kruse EB, Monsef I, Bohlius J, Schulz H, Engert A.

    Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007107. Review.PMID: 19160320 [PubMed - indexed for MEDLINE]Related articles

    5.

    Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.

    Bohlius J, Herbst C, Reiser M, Schwarzer G, Engert A.

    Cochrane Database Syst Rev. 2008 Oct 8;(4):CD003189. Review.PMID: 18843642 [PubMed - indexed for MEDLINE]Related articles

    6.

    Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.

    Bohlius J, Reiser M, Schwarzer G, Engert A.

    Cochrane Database Syst Rev. 2004;(3):CD003189. Review. Update in: Cochrane Database Syst Rev. 2008;(4):CD003189. PMID: 15266474 [PubMed - indexed for MEDLINE]Related articles

    7.

    Colony stimulating factors for chemotherapy induced febrile neutropenia.

    Clark OA, Lyman G, Castro AA, Clark LG, Djulbegovic B.

    Cochrane Database Syst Rev. 2003;(3):CD003039. Review.PMID: 12917942 [PubMed - indexed for MEDLINE]Related articles

    8.

    Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials.

    Wittman B, Horan J, Lyman GH.

    Cancer Treat Rev. 2006 Jun;32(4):289-303. Epub 2006 May 5. Review.PMID: 16678350 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.

    Kuderer NM, Dale DC, Crawford J, Lyman GH.

    J Clin Oncol. 2007 Jul 20;25(21):3158-67. Review.PMID: 17634496 [PubMed - indexed for MEDLINE]Related articles

    10.

    Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.

    Bohlius J, Reiser M, Schwarzer G, Engert A.

    Cochrane Database Syst Rev. 2004;(1):CD003189. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD003189. PMID: 14974009 [PubMed - indexed for MEDLINE]Related articles

    11.

    Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia.

    Sasse EC, Sasse AD, Brandalise S, Clark OA, Richards S.

    Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004139. Review.PMID: 16034921 [PubMed - indexed for MEDLINE]Related articles

    12.

    Granulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphoma.

    Bohlius J, Reiser M, Schwarzer G, Engert A.

    Cochrane Database Syst Rev. 2002;(4):CD003189. Review. Update in: Cochrane Database Syst Rev. 2004;(1):CD003189. PMID: 12519588 [PubMed - indexed for MEDLINE]Related articles

    13.

    Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.

    Gafter-Gvili A, Fraser A, Paul M, Leibovici L.

    Ann Intern Med. 2005 Jun 21;142(12 Pt 1):979-95. Erratum in: Ann Intern Med. 2006 May 2;144(9):704. PMID: 15968013 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer.

    Repetto L, Biganzoli L, Koehne CH, Luebbe AS, Soubeyran P, Tjan-Heijnen VC, Aapro MS.

    Eur J Cancer. 2003 Nov;39(16):2264-72. Review.PMID: 14556916 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis.

    Lyman GH, Kuderer NM, Djulbegovic B.

    Am J Med. 2002 Apr 1;112(5):406-11.PMID: 11904116 [PubMed - indexed for MEDLINE]Related articles

    16.

    Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review.

    Bohlius J, Reiser M, Schwarzer G, Engert A.

    Br J Haematol. 2003 Aug;122(3):413-23. Review.PMID: 12877668 [PubMed - indexed for MEDLINE]Related articles

    17.

    Colony-stimulating factors for the management of neutropenia in cancer patients.

    Dale DC.

    Drugs. 2002;62 Suppl 1:1-15. Review.PMID: 12479591 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.

    Thomas X, Boiron JM, Huguet F, Reman O, Sutton L, Turlure P, Garban F, Gardin C, Espinouse D, Boulat O, Lhéritier V, Fiere D; Groupe d'Etude et de Traitement de la Leucémie Aiguë Lymphoblastique de l'Adulte (GET-LALA Group).

    Hematol J. 2004;5(5):384-94.PMID: 15448664 [PubMed - indexed for MEDLINE]Related articles

    20.

    Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia.

    Gómez Raposo C, Pinto Marín A, González Barón M.

    Clin Transl Oncol. 2006 Oct;8(10):729-34. Review.PMID: 17074671 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data